Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab and irinotecan in primary brain tumors
NCT00463203Phase 2Completed
- Sponsor
- Rigshospitalet
- Start
- Mar 2007
- Primary completion
- Mar 2011
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in brain neoplasm, glioma, sponsored by Rigshospitalet. Started Mar 2007; status: completed.
02
Drugs
bevacizumab
03
Conditions
brain neoplasmglioma
Beyond the preview
Go deeper on NCT00463203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00463203.